1-carbamoyl-3-methylpyrazole,
3-methylpyrazole-1-carboxamide,
873-50-7,
3-Methyl-1H-pyrazole-1-carboxamide,
3-Methyl-1-pyrazolecarboxamide,
1H-Pyrazole-1-carboxamide, 3(or 5)-methyl-,
MFCD00020735,
100365-72-8,
3-methylpyrazolecarboxamide,
NSC75630,
AC1L69IE,
AC1Q2PO1,
NCIOpen2_000897,
SCHEMBL6685826,
CTK5F8270,
DTXSID10143235,
PNZZQMXKKNDHNS-UHFFFAOYSA-N,
NSC51116,
ZINC2566285,
7373AF,
NSC-51116,
NSC-75630,
SBB006629,
1H-Pyrazole-1-carboxamide,3-methyl-,
3-Methyl-1-pyrazolecarboxamide, 97%,
AKOS004907925,
MCULE-3435865301,
TR-032287,
FT-0616045,
ST50409319,
I14-50051,
CMP (nitrification inhibitor),
KMP (nitrification inhibitor),
1-Carbamoyl-3-methylpyrazole,
C5H7N3O,
1-Carbamoyl-3(5)-methylpyrazole,
N-(3-Methyl-1-pyrazolyl)formamide,
C5-H7-N3-O,
1H-Pyrazole-1-carboxamide, 3-methyl-,
EINECS 212-840-7,
CID242452,
NSC 51116,
NSC 75630,
3(or 5)-Methyl-1H-pyrazole-1-carboxamide,
BRN 0115536,
FORMAMIDE, N-(3-METHYL-1-PYRAZOLYL)-,
5-23-05-00010 (Beilstein Handbook Reference),
CMP,
KMP,